|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 March 2002, Vol. 99, No. 6, pp. 2100-2106
IMMUNOBIOLOGY
ALK as a novel lymphoma-associated tumor antigen: identification
of 2 HLA-A2.1-restricted CD8+ T-cell epitopes
Lorena Passoni,
Antonio Scardino,
Carla Bertazzoli,
Barbara Gallo,
Addolorata M. L. Coluccia,
François A. Lemonnier,
Konstadinos Kosmatopoulos, and
Carlo Gambacorti-Passerini
From the Oncogenic Fusion Genes and Proteins Unit,
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy;
INSERM U.487, Institut Gustave Roussy, Villejuif, France; and
Unité d'Immunité Cellulaire Antivirale, Department
SIDA-Retrovirus, Institut Pasteur, Paris, France.
Oncogenic anaplastic lymphoma kinase (ALK) fusion proteins (NPM/ALK
and associated variants) are expressed in about 60% of anaplastic
large cell lymphomas (ALCLs) but are absent in normal tissues. In this
study, we investigated whether ALK, which is expressed at high
levels in lymphoma cells, could be a target for antigen-specific
cell-mediated immunotherapy. A panel of ALK-derived peptides was tested
for their binding affinity to HLA-A*0201 molecules. Binding peptides
were assessed for their capacity to elicit a specific immune response
mediated by cytotoxic T lymphocytes (CTLs) both in vivo, in HLA-A*0201
transgenic mice, and in vitro in the peripheral blood lymphocytes
(PBLs) from healthy donors. Two HLA-A*0201-restricted CTL epitopes,
p280-89 (SLAMLDLLHV) and p375-86 (GVLLWEIFSL), both located in the ALK
kinase domain were identified. The p280-89- and
p375-86-induced peptide-specific CTL lines were able to specifically release interferon- (IFN-) on stimulation with ALK peptide-pulsed autologous Epstein-Barr virus-transformed B cells (LCLs) or T2 cells.
Anti-ALK CTLs lysed HLA-matched ALCL and neuroblastoma cell lines
endogenously expressing ALK proteins. CTL activity was inhibited by
anti-HLA-A2 monoclonal antibody CR11.351, consistent with a class
I-restricted mechanism of cytotoxicity. These results show the
existence of functional anti-ALK CTL precursors within the peripheral
T-cell repertoire of healthy donors, clearly indicating ALK as a tumor
antigen and ALK-derived peptides, p280-89 and p375-86, as suitable
epitopes for the development of vaccination strategies.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Marzec, Q. Zhang, A. Goradia, P. N. Raghunath, X. Liu, M. Paessler, H. Y. Wang, M. Wysocka, M. Cheng, B. A. Ruggeri, et al.
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
PNAS,
December 30, 2008;
105(52):
20852 - 20857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Rodig, J. Ouyang, P. Juszczynski, T. Currie, K. Law, D. S. Neuberg, G. A. Rabinovich, M. A. Shipp, and J. L. Kutok
AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
Clin. Cancer Res.,
June 1, 2008;
14(11):
3338 - 3344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wei, J.-T. Li, X.-P. Zhang, Y. Tang, J.-X. Wang, B. Zhang, and Y.-Z. Wu
Identification of an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope in rotavirus VP6 protein.
J. Gen. Virol.,
November 1, 2006;
87(Pt 11):
3393 - 3396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Zhou, D. Xu, X. Li, H. Li, M. Shan, J. Tang, M. Wang, F.-S. Wang, X. Zhu, H. Tao, et al.
Screening and Identification of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific CTL Epitopes
J. Immunol.,
August 15, 2006;
177(4):
2138 - 2145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kasprzycka, M. Marzec, X. Liu, Q. Zhang, and M. A. Wasik
From the Cover: Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
PNAS,
June 27, 2006;
103(26):
9964 - 9969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Chen, J. Hou, X. Jiang, S. Ma, M. Meng, B. Wang, M. Zhang, M. Zhang, X. Tang, F. Zhang, et al.
Response of Memory CD8+ T Cells to Severe Acute Respiratory Syndrome (SARS) Coronavirus in Recovered SARS Patients and Healthy Individuals
J. Immunol.,
July 1, 2005;
175(1):
591 - 598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Wang, H. Chen, X. Jiang, M. Zhang, T. Wan, N. Li, X. Zhou, Y. Wu, F. Yang, Y. Yu, et al.
Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein
Blood,
July 1, 2004;
104(1):
200 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J J Oudejans, R L ten Berge, and C J L M Meijer
Immune escape mechanisms in ALCL
J. Clin. Pathol.,
June 1, 2003;
56(6):
423 - 425.
[Full Text]
[PDF]
|
|
|
|
|
